Physician profile
Moshe Weiner
NPI 1013074889
$1,416.56
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,168 · 2020: $249.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $265.30 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $210.63 | 2019-2020 | |
| Genentech USA, INC. | $123.25 | 2019 | |
| Pfizer INC. | $122.36 | 2019-2020 | |
| Alexion Pharmaceuticals, INC. | $105.57 | 2019 | |
| Array Biopharma INC | $101.71 | 2019 | |
| Clovis Oncology, INC. | $99.95 | 2019 | |
| Janssen Biotech, INC. | $94.41 | 2019 | |
| Emd Serono, INC. | $67.82 | 2019 | |
| Merck Sharp & Dohme LLC | $38.42 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $37.47 | 2020 | |
| Astellas Pharma US INC | $37.32 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $36.81 | 2020 | |
| Incyte Corporation | $23.09 | 2019 | |
| Eisai INC. | $21.28 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Karyopharm Therapeutics INC. | $19.96 | 2020 | |
| Exelixis INC. | $11.21 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Moshe Weiner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.